Establishment and Clinical Application of Platelet Donor Registry with Known HLA Class Ⅰ and HPA Type in Qingdao Area, China

焦淑贤,迟晓云,冯智慧,刘晓华,孙波,周洪,胡彬,尹凤媛,乔显森,李长缨,赵林
DOI: https://doi.org/10.13303/j.cjbt.issn.1004-549x.2010.09.011
2010-01-01
Abstract:Objective To establish a voluntary apheresis platelet donor registry with HLA and HPA typings in Qingdao,in order to resolve the platelet transfusion refractoriness(PTR).Methods HLA classⅠ and HPA-1 to-5 and-15 system of 1 800 regular apheresis platelet donors in Qingdao region were genotyped by PCR-SSO and PCR-SSP,respectively.The effectiveness of three different platelet selection strategy,i.e.HLA antigen-negative,PLT cross-matching,and HLA specific matching,for alloimmunized PTR patients were compared.Results HLA and or HPA specific matching was better for severely alloimmunized patients(PRA60%),while for patients with PRA60%,the random cross-matching,antigen-negative selection and antigen-specific matching showed similar effect in treating the PTR.A registry of 1 800 platelet donors would enable more than 99% of patients to get at least one completely matched donor,and this theoretically estimated pool size was validated by the search results of patients with different HLA phenotypes.Conclusion In theory,a registry of about 6 000 local HLA class Ⅰ and HPA-typed platelet donors,is suitable for resolving PTR patients in Qingdao.Only severely alloimmunized patients need the completely matched platelets,while lightly alloimmunized patients can seek such alternatives as crossmatching or antigen-negtive strategy.
What problem does this paper attempt to address?